ACONW Aclarion WT leadership highlights targeted healthcare tech investments to fuel projected nearterm revenue growth GOODN Gladstone posts 51 percent Q4 2025 EPS beat even as shares dip 05 percent in todays trading Rezolve AI RZLV Stock Analysis Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss Is Entrada Therapeutics TRDA stock showing strong momentum Q4 2025 EPS Tops Views Is Banzai BNZIW stock risky for investors BNZIW Latest Fiscal Quarter Earnings Banzai discloses no core EPS or revenue data investors seek clarity